Literature DB >> 11804866

Prostacyclin analogs as the brakes for pulmonary artery smooth muscle cell proliferation: is it sufficient to treat severe pulmonary hypertension?

Rubin M Tuder1, Ari L Zaiman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804866     DOI: 10.1165/ajrcmb.26.2.f230

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  5 in total

Review 1.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

2.  Peroxisome Proliferator-activated Receptor γ and Mitochondria: Drivers or Passengers on the Road to Pulmonary Hypertension?

Authors:  Kurt R Stenmark; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2018-05       Impact factor: 6.914

Review 3.  Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?

Authors:  Steven K Huang; Marc Peters-Golden
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 4.  Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.

Authors:  Jeffrey M Peters; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2009-06-06

5.  Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion.

Authors:  Ami A Shah; Elena Schiopu; Laura K Hummers; Michael Wade; Kristine Phillips; Cynthia Anderson; Robert Wise; Francesco Boin; James R Seibold; Fredrick Wigley; Kristan D Rollins
Journal:  Arthritis Res Ther       Date:  2013-04-18       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.